Stock News
ICICI Securities Initiates Coverage On Leela Hotels With ‘BUY’, Sets ₹600 Target
ICICI Securities has initiated coverage on The Leela Palaces Hotels & Resorts (LEELA) with a ‘BUY’ rating and a target price of INR 600, implying a ~46% upside from the current market price of INR …
P/E 14–15x For A Rail Automation Niche, Value, Fair, Or Risky?
India’s infrastructure expansion is no longer a policy aspiration—it is an economic reality reshaping the nation’s industrial and logistics backbone. With a projected infrastructure investment of nearly INR 143 lakh crore (~USD 1.7 trillion) between …
57% Revenue CAGR And Expanding Margins—Should You Apply?
As India’s industrial landscape accelerates under the twin engines of Make in India and massive infrastructure investments, the demand for high-performance lubricants and specialty oils is surging. In this evolving ecosystem, Sundrex Oil Company — …
Warburg-Backed Avanse Financial Shelves IPO, Plans ₹1,374 Cr Rights Issue To Existing Investors
Mumbai-based education finance non-banking financial company (NBFC) Avanse Financial Services, backed by global investors Warburg Pincus, Kedaara Capital, and Mubadala, is preparing to raise INR 1,374 crore (~USD 152 million) through a rights issue to …
Practo Begins Early Banker Talks For IPO, Targets H2 CY26 Listing
Bengaluru health-tech platform opens early talks with bankers for Practo IPO; FY24 revenue at INR 240 crore, loss narrowed to INR 17 crore Practo Technologies is preparing to list in India in the second half …
Indore-based Global Leader In Steroidal-Hormone APIs Files For ₹2,180 Cr IPO
Symbiotec Pharmalab, a research-driven pharmaceutical and biotechnology company based in Indore, Madhya Pradesh, has filed DRHP with the Securities and Exchange Board of India (SEBI). Symbiotec Pharmalab IPO comprises a fresh issue and an offer …





